Alzheimer’s Therapeutic Research Institute
About the Institute
Located in San Diego, the institute is an integral part of the Keck School of Medicine of USC’s mission to create a leading hub of basic, translational and clinical research in neuroscience and neurological diseases by collaborating with sites and investigators around the world. USC ATRI promotes extensive collaboration and data sharing across academia, industry, regulators and advocacy groups with a focus on training future leaders in AD clinical research.
USC ATRI is funded by the National Institutes of Health (NIH), the Alzheimer’s Association, the Department of Defense, the pharmaceutical partners and advocacy groups to develop novel methods and engage in all phases of AD clinical trials as well as observational studies. Bringing broad expertise to a comprehensive array of partners, USC ATRI manages a portfolio of national and international multi-site studies.
Learn more about ATRI
Grants fund research into understanding Alzheimer’s disease risk factorIn partnership with the Alzheimer Disease Research Center of USC, Hussein Yassine, MD, assistant professor of medicine at the Keck School of Medicine of USC, was awarded two National Institutes of Health R01 grants totaling $6.7 million to conduct research that aims to further the medical community’s understanding of… Read More »
Keck School Events
Eli and Edythe Broad CIRM Center Auditorium, 1st floor conference room
11:00 am - 12:00 pm